ZA201002095B - Solid dispersion product of n-aryl urea-based drugs - Google Patents
Solid dispersion product of n-aryl urea-based drugsInfo
- Publication number
- ZA201002095B ZA201002095B ZA2010/02095A ZA201002095A ZA201002095B ZA 201002095 B ZA201002095 B ZA 201002095B ZA 2010/02095 A ZA2010/02095 A ZA 2010/02095A ZA 201002095 A ZA201002095 A ZA 201002095A ZA 201002095 B ZA201002095 B ZA 201002095B
- Authority
- ZA
- South Africa
- Prior art keywords
- solid dispersion
- based drugs
- dispersion product
- aryl urea
- urea
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99961807P | 2007-10-19 | 2007-10-19 | |
| PCT/EP2008/064076 WO2009050291A2 (en) | 2007-10-19 | 2008-10-17 | Solid dispersion product of n-aryl urea-based drugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201002095B true ZA201002095B (en) | 2011-11-30 |
Family
ID=40089463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2010/02095A ZA201002095B (en) | 2007-10-19 | 2010-03-24 | Solid dispersion product of n-aryl urea-based drugs |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP2197425A2 (en) |
| JP (1) | JP2011500649A (en) |
| KR (1) | KR20100087170A (en) |
| CN (1) | CN101827584A (en) |
| AU (1) | AU2008313622A1 (en) |
| BR (1) | BRPI0818340A2 (en) |
| CA (1) | CA2699301A1 (en) |
| CO (1) | CO6270206A2 (en) |
| CR (1) | CR11442A (en) |
| DO (1) | DOP2010000117A (en) |
| EC (1) | ECSP10010183A (en) |
| GT (1) | GT201000102A (en) |
| MX (1) | MX2010004291A (en) |
| PA (1) | PA8800101A1 (en) |
| RU (1) | RU2010119929A (en) |
| UA (1) | UA100865C2 (en) |
| WO (1) | WO2009050291A2 (en) |
| ZA (1) | ZA201002095B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009100176A2 (en) * | 2008-02-07 | 2009-08-13 | Abbott Laboratories | Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor |
| AR077975A1 (en) | 2009-08-28 | 2011-10-05 | Irm Llc | PIRAZOL PYRIMIDINE DERIVATIVES AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS |
| MX2012014387A (en) * | 2010-06-09 | 2013-05-01 | Abbvie Inc | Solid dispersions containing kinase inhibitors. |
| CA2855243C (en) | 2011-11-11 | 2020-04-14 | Novartis Ag | Method of treating a proliferative disease |
| LT2782557T (en) * | 2011-11-23 | 2018-12-27 | Array Biopharma, Inc. | Pharmaceutical formulations |
| WO2014003677A1 (en) * | 2012-06-28 | 2014-01-03 | Xspray Microparticles Ab | Pharmaceutical compositions comprising solid dispersion particles containing tadalafil |
| WO2014003678A1 (en) * | 2012-06-28 | 2014-01-03 | Xspray Microparticles Ab | Pharmaceutical compositions comprising ambrisentan and solid dispersion particles containing tadalafil |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070104780A1 (en) * | 2005-10-25 | 2007-05-10 | Lipari John M | Formulation comprising a drug of low water solubility and method of use thereof |
| WO2007066189A2 (en) * | 2005-12-09 | 2007-06-14 | Pfizer Products Inc. | Salts, prodrugs and formulations of 1-[5-(4-amino-7-isopropyl-7h-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2-methoxy-phenyl]-3-(2,4-dichloro-phenyl)-urea |
| EP2089003A1 (en) * | 2006-11-09 | 2009-08-19 | Abbott GmbH & Co. KG | Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor |
-
2008
- 2008-10-17 MX MX2010004291A patent/MX2010004291A/en not_active Application Discontinuation
- 2008-10-17 WO PCT/EP2008/064076 patent/WO2009050291A2/en active Application Filing
- 2008-10-17 AU AU2008313622A patent/AU2008313622A1/en not_active Abandoned
- 2008-10-17 CA CA2699301A patent/CA2699301A1/en not_active Abandoned
- 2008-10-17 KR KR1020107010979A patent/KR20100087170A/en not_active Application Discontinuation
- 2008-10-17 RU RU2010119929/15A patent/RU2010119929A/en not_active Application Discontinuation
- 2008-10-17 CN CN200880112150A patent/CN101827584A/en active Pending
- 2008-10-17 UA UAA201006029A patent/UA100865C2/en unknown
- 2008-10-17 PA PA20088800101A patent/PA8800101A1/en unknown
- 2008-10-17 EP EP08839333A patent/EP2197425A2/en not_active Withdrawn
- 2008-10-17 BR BRPI0818340 patent/BRPI0818340A2/en not_active IP Right Cessation
- 2008-10-17 JP JP2010529408A patent/JP2011500649A/en active Pending
-
2010
- 2010-03-24 ZA ZA2010/02095A patent/ZA201002095B/en unknown
- 2010-04-16 GT GT201000102A patent/GT201000102A/en unknown
- 2010-04-16 DO DO2010000117A patent/DOP2010000117A/en unknown
- 2010-04-27 CO CO10049271A patent/CO6270206A2/en not_active Application Discontinuation
- 2010-05-17 EC EC2010010183A patent/ECSP10010183A/en unknown
- 2010-05-19 CR CR11442A patent/CR11442A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DOP2010000117A (en) | 2010-05-15 |
| WO2009050291A2 (en) | 2009-04-23 |
| BRPI0818340A2 (en) | 2015-04-22 |
| UA100865C2 (en) | 2013-02-11 |
| CA2699301A1 (en) | 2009-04-23 |
| PA8800101A1 (en) | 2009-05-15 |
| JP2011500649A (en) | 2011-01-06 |
| EP2197425A2 (en) | 2010-06-23 |
| CO6270206A2 (en) | 2011-04-20 |
| CR11442A (en) | 2010-09-06 |
| CN101827584A (en) | 2010-09-08 |
| WO2009050291A3 (en) | 2010-04-08 |
| RU2010119929A (en) | 2011-11-27 |
| AU2008313622A1 (en) | 2009-04-23 |
| KR20100087170A (en) | 2010-08-03 |
| MX2010004291A (en) | 2010-08-02 |
| GT201000102A (en) | 2012-03-12 |
| ECSP10010183A (en) | 2010-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201002130B (en) | Solid dispersion product containing n-aryl urea-based compound | |
| EP2251038A4 (en) | Solid dispersion, pharmaceutical compositions containing the same, and processes for the production of both | |
| IL242883B (en) | Arylamino- and heteroarylamino-substituted dioxoazolines and pharmaceutical compositions comprising them | |
| IL200654A (en) | Benzyl and pyridinyl derivatives as modulators of the hedgehog signaling pathway and pharmaceutical compositions comprising them | |
| EP2150109A4 (en) | Pharmaceutical use of substituted amides | |
| IL199853A (en) | Substituted derivatives of 5-hydroxy-adamantyl-2-yl and pharmaceutical compositions comprising them | |
| IL202892A (en) | Dipeptoid prodrugs, process for their preparation and use thereof for preparation of medicaments and such medicaments | |
| HK1160762A1 (en) | Cartridge, pharmaceutical dispenser for solid pharmaceutical portions and applications of said cartridge and said pharmaceutical dispenser | |
| EP2187968A4 (en) | Thermo-kinetic mixing for pharmaceutical applications | |
| EP2265731A4 (en) | Methods and compositions for the assessment of drug response | |
| ZA201002095B (en) | Solid dispersion product of n-aryl urea-based drugs | |
| EP2166874A4 (en) | Microencapsulating compositions, methods of making, methods of using and products thereof | |
| HRP20181854T1 (en) | Slow release pharmaceutical composition made of microparticles | |
| AP2920A (en) | Anti-malarial pharmaceutical composition | |
| ZA200906179B (en) | Pharmaceutical formulations of GHRH molecules | |
| GB0813340D0 (en) | Facilitating dynamic configuration of software products | |
| IL208788A (en) | Solid pharmaceutical formulation | |
| PT2484661T (en) | 2,3-dihydro-1h-indene-2-ylurea derivative and pharmaceutical application of same | |
| EP2195332A4 (en) | Modulators of hypersensitivity reactions | |
| EP2471782A4 (en) | Novel sulfonamide derivative and pharmaceutical product containing same | |
| HK1131039A1 (en) | Pharmaceutical use of sophoricoside | |
| PL2410997T3 (en) | Composition for the administration of polymeric drugs |